Cannabigerol (CBG) is a non-intoxicating cannabinoid found in the cannabis plant that serves as a precursor to major cannabinoids such as CBD and THC. In this 2022 scientific review, researchers examined the pharmacological properties of CBG and its synthetic derivatives, highlighting evidence that CBG interacts with multiple biological targets involved in inflammation, pain signaling, neurological […]
Category: Wellness
CBD and CBG Demonstrate Antimicrobial Activity While Preserving Healthy Skin Microbiota (pub. Jan 2023)
A 2023 study examined the antimicrobial effects of cannabidiol (CBD) and cannabigerol (CBG) against bacteria commonly associated with skin conditions and infections. Researchers found that both cannabinoids were active against multiple bacterial species and biofilms, which are protective layers that make bacteria more resistant to treatment. The study also showed that CBD and CBG could […]
CBG Research Explores How Melanoma Cells Respond to Oxidative Stress and UVA Exposure (Pub. April 2026)
Researchers are continuing to study how hemp-derived cannabinoids interact with cellular stress and inflammation pathways. In the study “Metabolic responses of three distinct melanoma cell lines to UVA radiation and cannabigerol,” scientists examined how cannabigerol (CBG) affected melanoma cells exposed to UVA radiation. The research focused on oxidative stress, inflammation, and metabolic signaling pathways that […]